10-Q Filing

Silo Pharma, Inc. CIK: 1514183 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001213900-12-004111`
Period End Date	20120630
Filing Date	20120801
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	gldsw-20120630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 45 Income Statement 22 Cash Flow Statement 45 Stockholders Equity 23

Balance Sheet 45 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash	`Cash`	$813.00	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$1.75K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.75K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$813.00	USD	Point-in-time
Total Assets	`Assets`	$1.75K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$813.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.63M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.63M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.63M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.63M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.50K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.27K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$6.27K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.50K	USD	Point-in-time
Notes Payable	`LongTermNotesPayable`	$15.00K	USD	Point-in-time
Notes Payable	`LongTermNotesPayable`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$15.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.50K	USD	Point-in-time
Total Liabilities	`Liabilities`	$21.27K	USD	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.06K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 30,631,200 shares issued and outstanding	`CommonStockValue`	$3.06K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.12M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.15M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$1.13M	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-20.45K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.75K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$47.48K	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$1.75K	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$813.00	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.67K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$13.85K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$25.75K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.15M	USD	8 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$18.71K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-18.71K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-25.75K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-13.85K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.08M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-49.80K	USD	Annual
Net loss	`ProfitLoss`	$-1.15M	USD	8 Qtrs
Net loss	`ProfitLoss`	$-5.67K	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	8 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.40M	shares	8 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	1 Quarter
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	1 Quarter
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	2 Qtrs
Weighted average number of common shares outstanding during the period - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.63M	shares	2 Qtrs

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-18.71K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-25.75K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-13.85K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.08M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-49.80K	USD	Annual
Net loss	`ProfitLoss`	$-1.15M	USD	8 Qtrs
Net loss	`ProfitLoss`	$-5.67K	USD	1 Quarter
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	2 Qtrs
Stock issued for services - related parties	`ShareBasedCompensation`	$1.07M	USD	8 Qtrs
Stock issued for services - related parties	`ShareBasedCompensation`	-	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$3.50K	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$6.27K	USD	8 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$2.77K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.94K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.25K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-65.75K	USD	8 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	2 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$15.00K	USD	Point-in-time
Proceeds from notes payable	`ProceedsFromNotesPayable`	$15.00K	USD	2 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$15.00K	USD	8 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$575.00	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$51.56K	USD	8 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$15.00K	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$66.56K	USD	8 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$575.00	USD	2 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$813.00	USD	8 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-21.68K	USD	2 Qtrs
Net Increase (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-939.00	USD	2 Qtrs
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.48K	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$813.00	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$25.80K	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.48K	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$813.00	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.75K	USD	Point-in-time
Cash - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$25.80K	USD	Point-in-time
Income Taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income Taxes	`IncomeTaxesPaid`	-	USD	8 Qtrs
Income Taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	8 Qtrs
Interest	`InterestPaid`	-	USD	2 Qtrs

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Stock issued for services - related parties	`StockIssuedForServicesRelatedPartiesFairMarketValue`	$0.05	USD	2 Qtrs
Stock issued for cash, minimum fair market value	`StockIssuedForCashMinimumFairMarketValue`	$0.01	USD	2 Qtrs
Stock issued for cash, maximum fair market value	`StockIssuedForCashMaximumFairMarketValue`	$0.05	USD	2 Qtrs
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-20.45K	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.75K	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$47.48K	USD	Point-in-time
Shares, Outstanding	`SharesOutstanding`	0.00	shares	Point-in-time
Shares, Outstanding	`SharesOutstanding`	0.00	shares	Point-in-time
Shares, Outstanding	`SharesOutstanding`	0.00	shares	Point-in-time
Receipt of subscription receivable	`StockholdersEquityOther`	$575.00	USD	Annual
Net loss	`ProfitLoss`	$-18.71K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-25.75K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-13.85K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.08M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-49.80K	USD	Annual
Net loss	`ProfitLoss`	$-1.15M	USD	8 Qtrs
Net loss	`ProfitLoss`	$-5.67K	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-20.45K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.75K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$47.48K	USD	Point-in-time
Balance - (Shares)	`SharesOutstanding`	0.00	shares	Point-in-time
Balance - (Shares)	`SharesOutstanding`	0.00	shares	Point-in-time
Balance - (Shares)	`SharesOutstanding`	0.00	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.